This may end up hurting India not helping.

In order to get a drug approved in India, you need to run clinical trial on Indians. You also need to go to through the regulatory process, which isn't cheap.

If drug companies fear that the millions they spend on getting a drug approved in India won't be recouped because the gov't issues a compulsory license, then they simply won't do it.

I mean think about it... if introducing your product to a new market resulted in a net loss, would you do it?